1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global PARP Inhibitor Biomarkers Service Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 BRCA 1 & 2 Testing
  • 1.2.3 HRD Testing
  • 1.2.4 HRR Testing
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global PARP Inhibitor Biomarkers Service Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global PARP Inhibitor Biomarkers Service Market Perspective (2015-2026)
• 2.2 Global PARP Inhibitor Biomarkers Service Growth Trends by Regions
  • 2.2.1 PARP Inhibitor Biomarkers Service Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 PARP Inhibitor Biomarkers Service Historic Market Share by Regions (2015-2020)
  • 2.2.3 PARP Inhibitor Biomarkers Service Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top PARP Inhibitor Biomarkers Service Players by Market Size
  • 3.1.1 Global Top PARP Inhibitor Biomarkers Service Players by Revenue (2015-2020)
  • 3.1.2 Global PARP Inhibitor Biomarkers Service Revenue Market Share by Players (2015-2020)
• 3.2 Global PARP Inhibitor Biomarkers Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by PARP Inhibitor Biomarkers Service Revenue
• 3.4 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio
  • 3.4.1 Global PARP Inhibitor Biomarkers Service Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by PARP Inhibitor Biomarkers Service Revenue in 2019
• 3.5 Key Players PARP Inhibitor Biomarkers Service Area Served
• 3.6 Key Players PARP Inhibitor Biomarkers Service Product Solution and Service
• 3.7 Date of Enter into PARP Inhibitor Biomarkers Service Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 PARP Inhibitor Biomarkers Service Breakdown Data by Type (2015-2026)

• 4.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Type (2015-2020)
• 4.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Type (2021-2026)

5 PARP Inhibitor Biomarkers Service Breakdown Data by Application (2015-2026)

• 5.1 Global PARP Inhibitor Biomarkers Service Historic Market Size by Application (2015-2020)
• 5.2 Global PARP Inhibitor Biomarkers Service Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America PARP Inhibitor Biomarkers Service Market Size (2015-2026)
• 6.2 North America PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
• 6.3 North America PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
• 6.4 North America PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe PARP Inhibitor Biomarkers Service Market Size (2015-2026)
• 7.2 Europe PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
• 7.3 Europe PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
• 7.4 Europe PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China PARP Inhibitor Biomarkers Service Market Size (2015-2026)
• 8.2 China PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
• 8.3 China PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
• 8.4 China PARP Inhibitor Biomarkers Service Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan PARP Inhibitor Biomarkers Service Market Size (2015-2026)
• 9.2 Japan PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
• 9.3 Japan PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
• 9.4 Japan PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia PARP Inhibitor Biomarkers Service Market Size (2015-2026)
• 10.2 Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Type (2015-2020)
• 10.3 Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Application (2015-2020)
• 10.4 Southeast Asia PARP Inhibitor Biomarkers Service Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Myriad Genetics, Inc.
  • 11.1.1 Myriad Genetics, Inc. Company Details
  • 11.1.2 Myriad Genetics, Inc. Business Overview
  • 11.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Service Introduction
  • 11.1.4 Myriad Genetics, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020))
  • 11.1.5 Myriad Genetics, Inc. Recent Development
• 11.2 Hoffmann-La Roche AG
  • 11.2.1 Hoffmann-La Roche AG Company Details
  • 11.2.2 Hoffmann-La Roche AG Business Overview
  • 11.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Service Introduction
  • 11.2.4 Hoffmann-La Roche AG Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  • 11.2.5 Hoffmann-La Roche AG Recent Development
• 11.3 Invitae Corporation
  • 11.3.1 Invitae Corporation Company Details
  • 11.3.2 Invitae Corporation Business Overview
  • 11.3.3 Invitae Corporation PARP Inhibitor Biomarkers Service Introduction
  • 11.3.4 Invitae Corporation Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  • 11.3.5 Invitae Corporation Recent Development
• 11.4 NeoGenomics Laboratories, Inc.
  • 11.4.1 NeoGenomics Laboratories, Inc. Company Details
  • 11.4.2 NeoGenomics Laboratories, Inc. Business Overview
  • 11.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Service Introduction
  • 11.4.4 NeoGenomics Laboratories, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  • 11.4.5 NeoGenomics Laboratories, Inc. Recent Development
• 11.5 BPS Bioscience, Inc.
  • 11.5.1 BPS Bioscience, Inc. Company Details
  • 11.5.2 BPS Bioscience, Inc. Business Overview
  • 11.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Service Introduction
  • 11.5.4 BPS Bioscience, Inc. Revenue in PARP Inhibitor Biomarkers Service Business (2015-2020)
  • 11.5.5 BPS Bioscience, Inc. Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global PARP Inhibitor Biomarkers Service Scope and Market Size
PARP Inhibitor Biomarkers Service market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PARP Inhibitor Biomarkers Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others

Market segment by Application, split into
Hospital
Clinic
Others

Based on regional and country-level analysis, the PARP Inhibitor Biomarkers Service market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global PARP Inhibitor Biomarkers Service market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
...